Nabriva Therapeutics plc Contract Liability (Deferred Revenue)
Nabriva Therapeutics plc had Contract Liability (Deferred Revenue) of $374.00 thousand as of 2021-12-31, per its 10-K filed 2023-04-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2023-04-17
- 2021-12-31: Contract with Customer, Liability, Current $374.00K.
- 2021-09-30: Contract with Customer, Liability, Current $375.00K.
- 2021-06-30: Contract with Customer, Liability, Current $563.00K.
- 2021-03-31: Contract with Customer, Liability, Current $750.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2021-12-31 | $374.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $375.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $563.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $750.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $750.00K 10-K · filed 2022-03-29 |